Hyperbaric oxygen for invase fungal infections

Israel Medical Association Journal

Volumn 9, Issue 5, 2007, Pages 387-388

  Bitterman, Haim ^a,b  

^a CARMEL MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Aspergillus; Fungal infection; Hyperbaric oxygen; Hyperoxia; Mucormycosis

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; OXYGEN;

ANTIFUNGAL ACTIVITY; ASPERGILLOSIS; COHORT ANALYSIS; DISEASE MODEL; DRUG EXPOSURE; DRUG INDICATION; EDITORIAL; HUMAN; HYPERBARIC OXYGEN; HYPEROXIA; MICROORGANISM; MUCORMYCOSIS; MYCOSIS; NONHUMAN; PHAGOCYTOSIS; PROGNOSIS; SURVIVAL; MORTALITY; MULTIMODALITY CANCER THERAPY; NOTE;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; COMBINED MODALITY THERAPY; HUMANS; HYPERBARIC OXYGENATION; MUCORMYCOSIS;

EID: 34249733185     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. Segal E, Menhusen MH, Simmons S. Hyperbaric oxygen in the treatment of invasive fungal infections: a single-center experience. IMAJ 2007;19:355-7.
2. Bitterman N, Bitterman H. Oxygen toxicity. In: Mathiew D, ed. Handbook on Hyperbaric Medicine. Dordrecht: Springer, 2006:731-66.
3. Camporessi EM, Moon RE, Grande CM. Hyperbaric medicine: an integral part of trauma care. Crit Care Clin 1990;6:203-19.
4. Melamed Y, Shupak A, Bitterman H. Medical problems associated with underwater diving. N Engl J Med 1992;326:30-5.
5. Mathiew D, Linke JC, Wattel F. Non-healing wounds. In: Mathiew D, ed. Handbook on Hyperbaric Medicine. Dordrecht: Springer, 2006:401-27.
6. Brummelkamp WH, Hogendijk JL, Boerema I. Treatment of anaerobic infections (clostridial myositis) by drenching the tissues with oxygen under high atmospheric pressure. Surgery 1961;4:299-302.
7. Slack WK, Thomas DA, Perrins D. Hyperbaric oxygenation in chronic osteomyelitis. Lancet 1965;1:1093-4.
8. Park M. Effcts of hyperbaric oxygen in infectious diseases: basic mechanisms. In: Kindwall EP, Whelan HT, eds. Hyperbaric Medicine Practice. 2nd edn. Flagstaff, AZ: Best Publishing Company, 1999:205-43.
9. Mathieu D, Wattel F. Physiologic effects of hyperbaric oxygen on microorganisms and host defences against infection In: Mathiew D, ed. Handbook on Hyperbaric Medicine. Dordrecht: Springer, 2006:103-19.
10. Silver IA. Cellular microenvironment in healing and non-healing wounds. In Hunt TK, Heppenstall RB, Pines M, et al., eds. Soft and Hard Tissue Repair. New York: Praeger, 1984:50-66.
11. Gimbel ML, Hunt TK. Wound healing and hyperbaric oxygenation. In: Kindwall EP, Whelan HT, eds. Hyperbaric Medicine Practice. 2nd edn. Flagstaff, AZ: Best Publishing Company, 1999;169-204.
12. Cairney WJ. Effect of hyperbaric oxygen on certain growth features of Candida albicans. Aviat Space Environ Med 1978;49:956-8.
13. Gudewicz TM, Mader JT, Davis CP. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans. Aviat Space Environ Med 1987;58:673-8.
14. Ferguson BJ, Mitchell TG, Moon R, et al. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 1988;10:551-9.
15. Vaughan GL. Oxygen toxicity in a fission yeast. J Cell Physiol 1971; 77:363-71.
16. Galiazzo F, Schiesser A, Rotilio G. Glutathione peroxidase in yeast. Presence of the enzyme and induction by oxidative conditions. Biochem Biophys Res Commun 1987;18:974-9.
17. Gregory EM, Goscin SA, Fridovich I. Superoxide dismutase and oxygen toxicity in a eukaryote. J Bacteriol 1974;117:456-60.
18. Price JC, Stevens DL. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Larynogoscope 1980;90:737-47.
19. De La Paz MA, Patrinely JR, Marines HM, et at. Adjunctive hyperbaric oxygen in the treatment of bilateral cerebro-rhino-orbital mucormycosis. Am J Ophthalmol 1992;114:208-11.
20. Couch L, Theilen F, Mader JT, Rhinocereberal mucomycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol Head Neck Surg 1988;114:791-4.
21. Guevara N, Roy D, Dutruc-Rosset C, et al. Mucormycosis - early diagnosis and treatment. Rev Laryngol Otol Rhinol (Bord) 2004;125: 127-31.
22. Yohai RA, Bullock JD, Aziz AA, et al. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994;393-22.
23. Chassaing N, Valton L, Kony M, et al. Rhino-cerebral fungal infection successfully treated with supplementary hyperbaric oxygen therapy. Rev Neurol (Paris) 2003;159:1178-80.
24. Lo WL, Chang RF, Yang AH, et al. Aspergillosis of the temporo-mandibular joint following irradiation of the parotid region: a case report. Int J Oral Maxillofac Surg 2003;32:560-2.
25. Garcia-Covarrubias L, Barratt DM, Bartlett R, et al. Invasive aspergillosis treated with adjunctive hyperbaric oxygenation: a retrospective clinical series at a single institution. South Med J 2002; 95:450-6.